Multiple Myeloma Rounds ®

Multiple Myeloma Rounds ®

             We are excited to announce the formation of the Multiple Myeloma Rounds® !

                Please Join us at one of these Free CME/CE Accredited Dinner Programs in your area!

In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.

As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.  

We are pleased that in 2017 the Multiple Myeloma Rounds program has now grown to include a Committee of 36 multiple myeloma specialists from 24 different institutions who will be implementing the Multiple Myeloma Rounds program in 5 cities across the country!

This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.  

The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.

Please join us at one of the upcoming events!

The Multiple Myeloma Rounds Program Chairs and Committee Members

Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director:
Agne Paner, MD Rush University

Chicago Multiple Myeloma Rounds Regional Chairpersons
(A complete list of all 2017 Committee Members can be found on tab at top of page)

Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Agne Paner, MD Rush University
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
William Bensinger, MD Swedish Cancer Institute

 logo colors 04 text at bottomsmall           
12 252 LRF Final Logo             Plexus logo 1.28           Rush Logo MasterBrndTransparent                                      



Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 


This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

There is no fee for participating in this activity.

Educational Objectives:

1.  Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection

2.  Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes

3.  Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies

4.  Devise optimal evidence-based strategies for individualized treatment

5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management

Multiple Myeloma Rounds-2017: Treatment of Multiple Myeloma in a Rapidly Evolving Therapeutic Landscape: Application to Current Practice is supported by an educational grant from AbbVie, Amgen, Celgene Corporation, Incyte Corporation, Janssen Biotech, Inc., and Merck
Atlanta Multiple Myeloma Rounds Committee:

Emory University:
     Ajay Nooka, MD, MPH, FACP (Program Chair)

Cancer Treatment Centers of America: 
     Brion V. Randolph, MD

Georgia Cancer Specialists: 
     Kathleen Lambert, MD
     Lynn Zemsky, MD

Northwest Georgia Oncology Centers:
    Michael B. Andrews, MD

Piedmont Cancer Institute: 
     Ha Tran, MD

Suburban Hematology-Oncology Associates:
 Praveen Sivakumaran, MD

The Blood and Marrow Transplant Group of Georgia

     Asad Bashey, MD, PhD
    Scott R. Solomon, MD


Date: Thursday, February 15, 2018
Location: Holiday Inn North Shore
                 5300 W. Touhy Ave
                 Skokie, IL


5:30pm           Exhibits Open/Sign-In
6:15pm           Dinner
6:30pm           Opening Remarks

6:45 pm          Introduction of Case #1: Options for Induction and the Role of Transplant in 2018
                        Presented by:Tulio Rodriguez MD, Christie Hancock MD
                        Advocate Lutheran General Hospital

7:20 pm          Introduction of Case #2: Management After Transplant 
                        Presented by: Kevin Barton MD, Patrick Hagen MD, Daulath Singh, MD
                        Loyola University Medical Center

7:55 pm          Introduction of Case #3: Management of High-risk Multiple Myeloma in Patients Ineligible for Transplant
                        Presented by: Agne Paner MD, Bart Posnik MD
                        Rush University Medical Center and John H Stroger Jr Hospital of Cook County 

8:30pm       Closing Remarks/Q&A      
Chicago Multiple Myeloma Rounds Committee 

Loyola University Medical Center:
Kevin Barton, MD
      Patrick Hagen, MD

Advocate Lutheran General Hospital:
Tulio Rodriguez, MD

Medical College of Wisconsin:
Binod Dhakal, MD
     Parameswaran Hari, MD

Rush University Medical Center:
Agne Paner, MD, (Program Chair), Parameswaran Venugopal, MD, and John Maciejewski, MD

John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD    

University of Illinois at Chicago Medical Center:

    Pritesh Patel, MD

Florida Multiple Myeloma Rounds Committee

Moffitt Cancer Center:
    Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD

Date: Wednesday, February 7, 2018
Time: 5:30pm-8:30pm
  Brasserie 81/2 Restaurant
                  9 West 57th Street
                  New York, NY 10019


5:30 pm: Exhibits/Registration/Dinner

6:00 pm: Opening Remarks

6:30 pm: Introduction of Case #1: Managing Renal Insufficiency in Newly Diagnosed Multiple Myeloma
                Presented by: Adriana Rossi MD, Jorge Monge MD- Weill Cornell Medicine

7:00 pm: Introduction of Case #2: Treating Frail or Elderly Patients with Multiple Myeloma           
               Presented by: Deepu Madduri MD- The Mount Sinai Hospital

7:30 pm: Introduction of Case #3: Management of Multiple Myeloma Patients at First Relapse
                Presented by: Noa Biran MD, Miguel Velez Gonzalez MD- Hackensack University Medical Center

8:00 pm: Introduction of Case #4: Waldenstrom Macroglobulinemia
                Presented by: Divaya Bhutani, MD- Columbia University Medical Center

8:30 pm: Closing Remarks/Q&A

NYC/NJ Multiple Myeloma Rounds Committee

Memorial Sloan Kettering Cancer Center:
       Ola Landgren, MD (Program Chair)

Columbia University Medical Center:
       Suzanne Lentzsch, MD

Hackensack Medical Center:
        David Siegel, MD, Joshua Richter, MD, Noa Biran, MD, David Vesole, MD

Memorial Sloan Kettering Cancer Center:
        Neha S. Korde, MD

Mount Sinai Hospital:
       Sundar Jagannath, MD

Weill Cornell Medical Center:
       Ruben Niesvizky, MD, Roger N. Pearse, MD, Adriana Rossi, MD, Cara Rosenbaum, MD

Date: Thursday, March 29, 2018
Time: 6:00pm-8:30pm
Location: Renaissance Seattle Hotel
                 515 Madison St, Seattle WA

Seattle Multiple Myeloma Rounds Committee 

Swedish Cancer Institute:
     William Bensinger, MD (Program Chair)

Fred Hutchinson Cancer Center:
     Damian Green, MD

Seattle Cancer Care Alliance:
      Edward Libby, MD

Swedish Cancer Institute:
      Ami Batchelder, PA-C

The 2018 Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation

LRF Logo high res    logo colors 04 text at bottomsmall
If your company is interested in exhibiting at any of these events, please contact us at:


Phone: 1-866-607-4333
To register for one of the programs.. please click "REGISTER"

Categories: Symposia